<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>allergy and immunology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>allergy and immunology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy
Authors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O&#39;Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O&#39;Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/allergy-and-immunology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="allergy and immunology" />
<meta property="og:description" content="Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy
Authors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O&#39;Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O&#39;Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/allergy-and-immunology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-01-17T10:40:22+00:00" />
<meta property="article:modified_time" content="2024-01-17T10:40:22+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="allergy and immunology"/>
<meta name="twitter:description" content="Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy
Authors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O&#39;Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O&#39;Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "allergy and immunology",
      "item": "https://trxiv.yorks0n.com/posts/allergy-and-immunology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "allergy and immunology",
  "name": "allergy and immunology",
  "description": "Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy\nAuthors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O\u0026#39;Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O\u0026#39;Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K.",
  "keywords": [
    
  ],
  "articleBody": " Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy\nAuthors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O'Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O'Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K. B.; Gontrum, E. Q.; Chan, B.; Kramer, J. H.; Wilson, M. R.; Utz, P. J.; Hill, J. A.; Jackson, S. W.; Anderson, M. S.; DeRisi, J. L.\nScore: 7.6, Published: 2023-12-20 DOI: 10.1101/2023.12.19.23300188\nThe prevalence and burden of autoimmune and autoantibody mediated disease is increasing worldwide, yet most disease etiologies remain unclear. Despite numerous new targeted immunomodulatory therapies, comprehensive approaches to apply and evaluate the effects of these treatments longitudinally are lacking. Here, we leverage advances in programmable-phage immunoprecipitation (PhIP-Seq) methodology to explore the modulation, or lack thereof, of proteome-wide autoantibody profiles in both health and disease. We demonstrate that each individual, regardless of disease state, possesses a distinct set of autoreactivities constituting a unique immunological fingerprint, or \"autoreactome\", that is remarkably stable over years. In addition to uncovering important new biology, the autoreactome can be used to better evaluate the relative effectiveness of various therapies in altering autoantibody repertoires. We find that therapies targeting B-Cell Maturation Antigen (BCMA) profoundly alter an individuals autoreactome, while anti-CD19 and CD-20 therapies have minimal effects, strongly suggesting a rationale for BCMA or other plasma cell targeted therapies in autoantibody mediated diseases.\nAssociation between antinuclear antibodies (ANA) patterns and extractable nuclear antigens (ENA) in patients with autoimmune diseases\nAuthors: Haris, A. R.; Tipu, H. N.; Ahmed, D.; Nabeel, M. A.; Akhtar, M. S.\nScore: 1.1, Published: 2024-01-04 DOI: 10.1101/2024.01.04.24300829\nBackgroundAntinuclear antibodies (ANA) and extractable nuclear antigens (ENA) are crucial biomarkers for the diagnosis of autoimmune diseases (AID) such as systemic lupus erythematosus (SLE), Sjogrens syndrome, systemic sclerosis, and polymyositis. In the present study, we assessed the most frequent ANA patterns associated with the most detectable ENA antigen (Ag) that could be used as a diagnostic and efficient prognostic marker of AID. Materials and MethodsThe primary objective of this study was to investigate the association between immunofluorescence (IF) ANA and ENA in patients with AIDs. This was a retrospective cross-sectional study. The study was performed at the Immunology Department of the Armed Forces Institute of Pathology, Rawalpindi. Retrospective data from 76 patients were tested for ANA and ENA from June 2020 to Nov 2020. ResultsA total of 76 patients comprising 14 (18.4%) males and 62(81.6%) females were tested for AIDs. The most frequent pattern among AID patients was coarse speckled, followed by the peripheral ANA pattern. The most frequent ENA Ags were Sjogrens syndrome A (SSA) and B (SSB). SSA was significantly associated with coarse speckled and peripheral ANA patterns, whereas SSB was associated with coarse speckled ANA patterns. These associations are relevant for accurate diagnosis of autoimmune diseases. ConclusionSSA was associated with coarse speckled and peripheral ANA patterns, whereas SSB was associated with coarse speckled ANA patterns. The ANA patterns were significantly associated with ENA antigens.\n",
  "wordCount" : "523",
  "inLanguage": "en",
  "datePublished": "2024-01-17T10:40:22Z",
  "dateModified": "2024-01-17T10:40:22Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/allergy-and-immunology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      allergy and immunology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on January 17, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.19.23300188">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.19.23300188" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.19.23300188">
        <p class="paperTitle">Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.19.23300188" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.19.23300188" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O&#39;Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O&#39;Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K. B.; Gontrum, E. Q.; Chan, B.; Kramer, J. H.; Wilson, M. R.; Utz, P. J.; Hill, J. A.; Jackson, S. W.; Anderson, M. S.; DeRisi, J. L.</p>
        <p class="info">Score: 7.6, Published: 2023-12-20 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.19.23300188' target='https://doi.org/10.1101/2023.12.19.23300188'> 10.1101/2023.12.19.23300188</a></p>
        <p class="abstract">The prevalence and burden of autoimmune and autoantibody mediated disease is increasing worldwide, yet most disease etiologies remain unclear. Despite numerous new targeted immunomodulatory therapies, comprehensive approaches to apply and evaluate the effects of these treatments longitudinally are lacking. Here, we leverage advances in programmable-phage immunoprecipitation (PhIP-Seq) methodology to explore the modulation, or lack thereof, of proteome-wide autoantibody profiles in both health and disease. We demonstrate that each individual, regardless of disease state, possesses a distinct set of autoreactivities constituting a unique immunological fingerprint, or &#34;autoreactome&#34;, that is remarkably stable over years. In addition to uncovering important new biology, the autoreactome can be used to better evaluate the relative effectiveness of various therapies in altering autoantibody repertoires. We find that therapies targeting B-Cell Maturation Antigen (BCMA) profoundly alter an individuals autoreactome, while anti-CD19 and CD-20 therapies have minimal effects, strongly suggesting a rationale for BCMA or other plasma cell targeted therapies in autoantibody mediated diseases.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.04.24300829">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.04.24300829" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.04.24300829">
        <p class="paperTitle">Association between antinuclear antibodies (ANA) patterns and extractable nuclear antigens (ENA) in patients with autoimmune diseases</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.04.24300829" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.04.24300829" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Haris, A. R.; Tipu, H. N.; Ahmed, D.; Nabeel, M. A.; Akhtar, M. S.</p>
        <p class="info">Score: 1.1, Published: 2024-01-04 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.04.24300829' target='https://doi.org/10.1101/2024.01.04.24300829'> 10.1101/2024.01.04.24300829</a></p>
        <p class="abstract">BackgroundAntinuclear antibodies (ANA) and extractable nuclear antigens (ENA) are crucial biomarkers for the diagnosis of autoimmune diseases (AID) such as systemic lupus erythematosus (SLE), Sjogrens syndrome, systemic sclerosis, and polymyositis. In the present study, we assessed the most frequent ANA patterns associated with the most detectable ENA antigen (Ag) that could be used as a diagnostic and efficient prognostic marker of AID.

Materials and MethodsThe primary objective of this study was to investigate the association between immunofluorescence (IF) ANA and ENA in patients with AIDs. This was a retrospective cross-sectional study. The study was performed at the Immunology Department of the Armed Forces Institute of Pathology, Rawalpindi. Retrospective data from 76 patients were tested for ANA and ENA from June 2020 to Nov 2020.

ResultsA total of 76 patients comprising 14 (18.4%) males and 62(81.6%) females were tested for AIDs. The most frequent pattern among AID patients was coarse speckled, followed by the peripheral ANA pattern. The most frequent ENA Ags were Sjogrens syndrome A (SSA) and B (SSB). SSA was significantly associated with coarse speckled and peripheral ANA patterns, whereas SSB was associated with coarse speckled ANA patterns. These associations are relevant for accurate diagnosis of autoimmune diseases.

ConclusionSSA was associated with coarse speckled and peripheral ANA patterns, whereas SSB was associated with coarse speckled ANA patterns. The ANA patterns were significantly associated with ENA antigens.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
